A path toward clinical trial diversity
Minority and marginalized communities have historically been underrepresented in local and federal governments and in dozens of private sectors globally. Pharma is no different; there exists a steep chasm that drugmakers have yet to bridge concerning research and trials. The longer this gulf exists, the harder it becomes to address – the feelings of mistrust, resentment, and disenfranchisement only get harder to overcome with time.
Over the last decade, the pharmaceutical …








![Medical brain drain leaves vulnerable communities without life-saving care [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)
![Collaborative partnerships save rural health care from collapse [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)

